Abstract
Introduction: Ring chromosome 22 (r[22]) can lead to the development of intracranial tumors such as meningiomas, neurofibromas, and schwannomas similar to neurofibromatosis 2 (NF2). Case Presentation: An 18-year-old female with r(22) and a history of global development delay and cognitive impairment presented with sudden hearing loss. MRI revealed bilateral vestibular schwannomas. Given documented audiologic decline in the patient’s hearing, the larger tumor was treated with CyberKnife fractionated stereotactic radiosurgery, and the smaller tumor is being monitored. Conclusion: This case provides further evidence that patients with r(22) can develop clinical features of NF2, including the development of bilateral vestibular schwannomas, and should be monitored for hearing disturbances starting in puberty as a warning sign for these tumors.
References
1.
Mahajan
S
, Kaur
A
, Singh
J
. Ring chromosome 22: a review of the literature and first report from India
. Balkan J Med Genet
. 2012
;15
(1
):55
–9
. .2.
Denayer
E
, Brems
H
, de Cock
P
, Evans
GD
, Van Calenbergh
F
, Bowers
N
, et al Pathogenesis of vestibular schwannoma in ring chromosome 22
. BMC Med Genet
. 2009
;10
:97
. .3.
Trofatter
JA
, MacCollin
MM
, Rutter
JL
, Murrell
JR
, Duyao
MP
, Parry
DM
, et al A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
. Cell
. 1993
;72
(5
):791
. .4.
Agrawal
H
, Mery
CM
, Sexson Tejtel
SK
, Fraser
CD
, McKenzie
ED
, Qureshi
AM
, et al Familial clustering of cardiac conditions in patients with anomalous aortic origin of a coronary artery and myocardial bridges
. Cardiol Young
. 2018
;28
(9
):1099
–105
. .5.
Zirn
B
, Arning
L
, Bartels
I
, Shoukier
M
, Hoffjan
S
, Neubauer
B
, et al Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma
. Clin Genet
. 2012
;81
(1
):82
–7
. .6.
Kehrer-Sawatzki
H
, Udart
M
, Krone
W
, Baden
R
, Fahsold
R
, Thomas
G
, et al Mutational analysis and expression studies of the neurofibromatosis type 2 (NF2) gene in a patient with a ring chromosome 22 and NF2
. Hum Genet
. 1997
;100
(1
):67
–74
. .7.
Tsilchorozidou
T
, Menko
FH
, Lalloo
F
, Kidd
A
, De Silva
R
, Thomas
H
, et al Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2
. J Med Genet
. 2004
;41
(7
):529
–34
. .8.
Celis-Aguilar
E
, Lassaletta
L
, Torres-Martín
M
, Rodrigues
FY
, Nistal
M
, Castresana
JS
, et al The molecular biology of vestibular schwannomas and its association with hearing loss: a review
. Genet Res Int
. 2012
;2012
:856157
. .9.
Aghi
M
, Kluwe
L
, Webster
MT
, Jacoby
LB
, Barker
FG
2nd, Ojemann
RG
, et al Unilateral vestibular schwannoma with other neurofibromatosis type 2-related tumors: clinical and molecular study of a unique phenotype
. J Neurosurg
. 2006
;104
(2
):201
–7
. .10.
Castellanos
E
, Bielsa
I
, Carrato
C
, Rosas
I
, Solanes
A
, Hostalot
C
, et al Segmental neurofibromatosis type 2: discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb
. BMC Med Genomics
. 2015
;8
:2
. .11.
Evans
DG
, Huson
SM
, Donnai
D
, Neary
W
, Blair
V
, Newton
V
, et al A clinical study of type 2 neurofibromatosis
. Q J Med
. 1992
;84
(304
):603
–18
..12.
Knudson
AG
Jr. Mutation and cancer: statistical study of retinoblastoma
. Proc Natl Acad Sci U S A
. 1971
;68
(4
):820
–3
. .13.
Evans
DG
. Neurofibromatosis type 2 (NF2): a clinical and molecular review
. Orphanet J Rare Dis
. 2009
;4
:16
. .14.
Tommerup
N
, Warburg
M
, Gieselmann
V
, Hansen
BR
, Koch
J
, Petersen
GB
. Ring chromosome 22 and neurofibromatosis
. Clin Genet
. 1992
;42
(4
):171
–7
. .15.
Aslan
A
, De Donato
G
, Balyan
FR
, Falcioni
M
, Russo
A
, Taibah
A
, et al Clinical observations on coexistence of sudden hearing loss and vestibular schwannoma
. Otolaryngol Head Neck Surg
. 1997
;117
(6
):580
–2
. .16.
Rosahl
S
, Bohr
C
, Lell
M
, Hamm
K
, Iro
H
. Diagnostics and therapy of vestibular schwannomas: an interdisciplinary challenge
. GMS Curr Top Otorhinolaryngol Head Neck Surg
. 2017
;16
:Doc03
. .17.
Magdziarz
DD
, Wiet
RJ
, Dinces
EA
, Adamiec
LC
. Normal audiologic presentations in patients with acoustic neuroma: an evaluation using strict audiologic parameters
. Otolaryngol Head Neck Surg
. 2000
;122
(2
):157
–62
. .18.
Myrseth
E
, Møller
P
, Wentzel-Larsen
T
, Goplen
F
, Lund-Johansen
M
. Untreated vestibular schwannomas: vertigo is a powerful predictor for health-related quality of life
. Neurosurgery
. 2006
;59
(1
):67
–76
. discussion 67–76
. .19.
Halliday
J
, Rutherford
SA
, McCabe
MG
, Evans
DG
. An update on the diagnosis and treatment of vestibular schwannoma
. Expert Rev Neurother
. 2018
;18
(1
):29
–39
. .20.
Maniakas
A
, Saliba
I
. Microsurgery versus stereotactic radiation for small vestibular schwannomas: a meta-analysis of patients with more than 5 years’ follow-up
. Otol Neurotol
. 2012
;33
(9
):1611
–20
. .© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
